First Time Loading...

Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.485 AUD Market Closed
Updated: May 8, 2024

Immutep Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immutep Ltd
Cash from Financing Activities Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Immutep Ltd
ASX:IMM
Cash from Financing Activities
AU$76m
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
19%
Mesoblast Ltd
ASX:MSB
Cash from Financing Activities
$67.8m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cash from Financing Activities
-$1.6B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-8%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Financing Activities
-AU$2.7m
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Financing Activities
AU$10.2m
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cash from Financing Activities
AU$28.8m
CAGR 3-Years
-9%
CAGR 5-Years
27%
CAGR 10-Years
22%

See Also

What is Immutep Ltd's Cash from Financing Activities?
Cash from Financing Activities
76m AUD

Based on the financial report for Dec 31, 2023, Immutep Ltd's Cash from Financing Activities amounts to 76m AUD.

What is Immutep Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
19%

The average annual Cash from Financing Activities growth rates for Immutep Ltd have been 15% over the past three years , 29% over the past five years , and 19% over the past ten years .